申请人:US GOV HEALTH & HUMAN SERV
公开号:WO2005007614A1
公开(公告)日:2005-01-27
The invention includes compounds of formula (I), pharmaceutically acceptable salts thereof, compositions containing compounds of formula (I), methods of inhibiting at least one monoamine oxidase using a compound of formula (I), and methods of inhibiting one amine oxidase while inhibiting another amine oxidase to a lesser degree using a compound of formula (I). Wherein each X is independently, an electron donating group, or an electron withdrawing group; n is an integer from 0 to 3 and Y is formula (II), (III), (IV), (V) (VI); wherein E is an electron donating group, and z is an integer from 0 to 3 with the proviso than when Y is formula (VII) or formula (VIII) where the cyclopropyl ring is attached at the carbon substituted with the E, X is not H; or pharmaceutically acceptable salts thereof.
该发明涵盖了式(I)的化合物,其药学上可接受的盐,含有式(I)化合物的组合物,使用式(I)化合物抑制至少一种单胺氧化酶的方法,以及使用式(I)化合物抑制一种胺氧化酶而对另一种胺氧化酶的抑制程度较小的方法。其中每个X独立地是一个给电子基团或一个吸电子基团;n是从0到3的整数,Y是式(II),(III),(IV),(V)(VI);其中E是一个给电子基团,z是从0到3的整数,但当Y是式(VII)或式(VIII)时,环丙基环与E取代的碳上,X不是H;或其药学上可接受的盐。